Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05044793 · ClinicalTrials.gov registry record
A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System
A clinical trial of Glaucoma Open-Angle, sponsored by Sight Sciences.
- Completed
- Registry status
- 70
- Enrollment target
- 4
- Study locations
NCT05044793: Completed study of Glaucoma Open-Angle, sponsored by Sight Sciences.
NCT05044793 is a study of Glaucoma Open-Angle that has completed, run by Sight Sciences. The registered enrollment target is 70 participants, below the 162-participant average among 22 other Glaucoma Open-Angle trials with a reported enrollment target (57% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05044793, a study of Glaucoma Open-Angle, has completed, sponsored by Sight Sciences.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to evaluate the long-term safety and effectiveness of the OMNI® Surgical System in subjects who were treated under protocol #06213
Primary Outcome
Rate of occurrence of sight-threatening adverse events
Conditions Studied
Interventions
- DEVICE OMNI® Surgical System
Study Locations (4)
Kansas
- Grene Vision Group - Wichita
Oklahoma
- Oklahoma Eye Surgeons - Oklahoma City
Pennsylvania
- Northern Ophthalmics - Jenkintown
Texas
- El Paso Eye Surgeons - El Paso
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2023-08-21 |
What the finished NCT05044793 record still lists
NCT05044793 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 162-participant average among 22 other Glaucoma Open-Angle trials with a reported enrollment target (57% lower).
The record links to 1 condition, with Glaucoma Open-Angle appearing as the primary indexed condition, and to 1 intervention - of which OMNI® Surgical System is the first listed.
NCT05044793 reports a single indexed study location in Kansas, Oklahoma, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05044793 about?
NCT05044793 is a clinical study titled "A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System". The purpose of this study is to evaluate the long-term safety and effectiveness of the OMNI® Surgical System in subjects who were treated under protocol #06213
What is the current status of trial NCT05044793?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2021-09-01. Estimated completion is 2023-08-21.
What conditions does trial NCT05044793 study?
This clinical trial studies the following conditions: Glaucoma Open-Angle.
What interventions are being tested in trial NCT05044793?
The interventions under investigation include: OMNI® Surgical System (DEVICE).
Who is sponsoring clinical trial NCT05044793?
This trial is sponsored by Sight Sciences, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05044793 being conducted?
This trial has 4 study locations across Kansas, Oklahoma, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma Open-Angle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05044793's enrollment target sits among peer trials
70 15th of 22 higher than 8 of 22 other Glaucoma Open-Angle trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Glaucoma Open-Angle trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
RECRUITING
-
Electrical Stimulation for Vision Neuroenhancement in Glaucoma
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Optic Neuropathies
RECRUITING · NA
-
Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone
RECRUITING · Phase 3
-
Electrical Stimulation for the Treatment of Glaucoma
RECRUITING · NA
-
Optic Nerve Head Strain as Biomarker for Glaucoma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI